Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study.
暂无分享,去创建一个
Yasunari Kanda | Kentaro Ando | Kohei Sawada | Yuko Sekino | Atsushi Sugiyama | Y. Sekino | K. Sawada | Y. Kanda | A. Sugiyama | Atsuko Ojima | N. Miyamoto | Kentaro Ando | Atsuko Ojima | Norimasa Miyamoto | Junko Matsuo | Yuji Nakamura | Yuji Nakamura | J. Matsuo
[1] Kelly Rae Chi. Revolution dawning in cardiotoxicity testing , 2013, Nature Reviews Drug Discovery.
[2] A. V. van Ginneken,et al. Effects of delayed rectifier current blockade by E-4031 on impulse generation in single sinoatrial nodal myocytes of the rabbit. , 1995, Circulation research.
[3] J. Weiss,et al. Genesis of Phase 3 Early Afterdepolarizations and Triggered Activity in Acquired Long-QT Syndrome , 2011, Circulation. Arrhythmia and electrophysiology.
[4] J. Brachmann,et al. Electrophysiological Effects of E 4031, a Drug with Selective Class III Properties, in Man , 1997, Pacing and clinical electrophysiology : PACE.
[5] C. January,et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.
[6] Thomas Rau,et al. Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology , 2011, PloS one.
[7] T. Fujita,et al. QT/QTc study conducted in Japanese adult healthy subjects: A novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation , 2014, Journal of clinical pharmacology.
[8] N. Kohmura,et al. A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.
[9] M. Tabo,et al. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart. , 2010, The Journal of toxicological sciences.
[10] H. Inoue,et al. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. , 1994, Journal of cardiovascular pharmacology.
[11] J Jalife,et al. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart. , 1997, Journal of the American College of Cardiology.
[12] Keiji Yamamoto,et al. QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans. , 2005, Journal of pharmacological sciences.
[13] M. Sanguinetti,et al. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. , 1991, Circulation research.
[14] James A Thomson,et al. Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes: Action Potential Characterization , 2003, Circulation research.
[15] Shinsuke Yuasa,et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. , 2009, Biochemical and biophysical research communications.
[16] J. Brouillette,et al. Characterization of ventricular repolarization in male and female guinea pigs. , 2007, Journal of molecular and cellular cardiology.
[17] Ricardo Bolaños,et al. QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications. , 2010, Current drug safety.
[18] U. Ravens,et al. Effects of the New Class III Antiarrhythmic Drug E‐4031 on Myocardial Contractility and Electrophysiological Parameters , 1991, Journal of cardiovascular pharmacology.
[19] G Duker,et al. Comparison of the IKr blockers moxifloxacin, dofetilide and E‐4031 in five screening models of pro‐arrhythmia reveals lack of specificity of isolated cardiomyocytes , 2012, British journal of pharmacology.
[20] Lior Gepstein,et al. Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.
[21] Borje Darpo,et al. THEMED SECTION: QT SAFETY REVIEW The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance , 2010 .